Lipid Screening & Cardiovascular Risk¶
Learning Objectives¶
Core Knowledge & Clinical Reasoning¶
- [ ] Apply universal lipid screening protocol (ages 9-11 and 17-21)
- [ ] Identify indications for targeted screening in younger children (family history, obesity, high-risk conditions)
- [ ] Interpret pediatric-specific lipid cut points (LDL ≥130 high, ≥160 suspect FH)
- [ ] Recognize familial hypercholesterolemia and indications for genetic testing
Management Decisions¶
- [ ] Prescribe lifestyle modifications using CHILD-1/CHILD-2 diets
- [ ] Determine pharmacotherapy indications (age ≥10, LDL thresholds by risk factors)
- [ ] Select appropriate statin therapy for pediatric patients
Communication & Counseling¶
- [ ] Counsel families on cardiovascular risk reduction and atherosclerosis prevention
- [ ] Explain rationale for screening even without family history (unreliability of family history)
- [ ] Address concerns about statin use in children when indicated
Systems-Based Practice¶
- [ ] Implement universal screening into well-child care protocols
- [ ] Coordinate cascade testing for families with identified FH
Key Guidelines¶
2011 NHLBI Expert Panel: Integrated Guidelines for CV Health and Risk Reduction in Children Pediatrics. 2011;128(Suppl):S213-256 AAP Endorsed; Remains Current
Universal Screening¶
| Age | Recommendation |
|---|---|
| 9-11 years | Universal non-fasting lipid screen |
| 17-21 years | Second universal screen |
Rationale¶
- Family history unreliable for identifying dyslipidemia
- Early atherosclerosis is present and preventable
- FH prevalence ~1:250 (underdiagnosed)
Targeted Screening (Ages 2-8 Years)¶
Screen if ANY of the following: - Family history of early CVD (<55 years male, <65 years female) - Family history of dyslipidemia - Parent with TC ≥240 mg/dL - BMI ≥95th percentile - Diabetes, hypertension, or tobacco use - High-risk conditions: - Chronic kidney disease - Kawasaki disease with coronary aneurysms - Solid organ transplant - Childhood cancer survivor
Lipid Cut Points for Children¶
| Lipid | Acceptable | Borderline | High |
|---|---|---|---|
| Total Cholesterol | <170 | 170-199 | ≥200 |
| LDL-C | <110 | 110-129 | ≥130 |
| Non-HDL-C | <120 | 120-144 | ≥145 |
| TG (0-9 years) | <75 | 75-99 | ≥100 |
| TG (10-19 years) | <90 | 90-129 | ≥130 |
| HDL-C | >45 | 40-45 | <40 (low) |
All values in mg/dL
Screening Method¶
Non-Fasting Lipid Panel¶
- Preferred for screening
- TC, HDL-C, Non-HDL-C valid non-fasting
- If Non-HDL-C ≥145 or HDL <40 → repeat fasting
Fasting Lipid Panel¶
- Confirm abnormal screening
- Required for accurate TG and LDL-C calculation
Familial Hypercholesterolemia (FH)¶
Suspect FH if:¶
- LDL-C ≥160 mg/dL (pediatric threshold)
- Family history of early CVD or high cholesterol
- Tendon xanthomas (rare in children)
Genetic Testing¶
- Consider if LDL-C ≥190 mg/dL
- Cascade testing if proband positive
Management¶
Lifestyle Modifications (All Patients)¶
- CHILD-1 diet (low saturated fat, no trans fat)
- Regular physical activity
- Weight management if overweight/obese
- Avoid tobacco exposure
Pharmacotherapy Indications¶
Age ≥10 years with: - LDL-C ≥190 mg/dL despite diet, OR - LDL-C ≥160 mg/dL + family history or other risk factors, OR - LDL-C ≥130 mg/dL + diabetes
Statins are first-line (multiple are FDA-approved for pediatric use)
2023 USPSTF Statement¶
- "Insufficient evidence" to assess benefits/harms of universal screening
- Does NOT recommend against screening
- Acknowledges NHLBI/AAP guidance
- Continues to generate controversy
Board Pearls¶
Pearl: Universal screening at 9-11 years and 17-21 years
Non-fasting lipid panel; family history is unreliable
Pearl: Pediatric LDL-C ≥160 = suspect FH
Lower threshold than adults; early detection critical
Pearl: Non-HDL-C: Most useful non-fasting marker
Calculate as: TC - HDL-C
Self-Assessment¶
Q1: A healthy 10-year-old presents for a well-child check. Mother's cholesterol is unknown. What lipid screening is indicated?
Answer
**Answer**: Universal non-fasting lipid screening **Rationale**: Per NHLBI/AAP guidelines, all children should have universal lipid screening at ages 9-11 years. This does not depend on family history, which is unreliable for identifying dyslipidemia.Q2: A 7-year-old with BMI at 97th percentile has fasting lipids: TC 210, LDL 145, HDL 38, TG 135. What is the interpretation and management?
Answer
**Answer**: High LDL-C, low HDL-C, borderline TG; lifestyle modification first **Rationale**: LDL 145 is high (≥130), HDL 38 is low (<40), TG is borderline-high for age. In a 7-year-old, lifestyle modifications (CHILD-1/CHILD-2 diet, exercise, weight management) are first-line. Pharmacotherapy is generally reserved for age ≥10 with more severe elevations or FH.Related Topics¶
- Pediatric Hypertension - CV risk
- Kawasaki Disease - Coronary risk
- ACHD - Long-term CV health
- Heart Failure - Atherosclerotic complications
- Sports Cardiology - Athletic screening
References¶
- NHLBI Expert Panel. Pediatrics. 2011;128(Suppl):S213-256
- USPSTF Statement 2023